Introduction
Open lung biopsy (OLB) is the gold standard test for many lung diseases which present with acute respiratory failure and diffuse pulmo-nary infiltrates 1 . It is, however, an invasive procedure, and thus employed only when other, less invasive, methods have been tried or when a precise diagnosis is needed quickly 1 .
The available evidence on the safety and diagnostic yield of OLB in critically ill patients on mechanical ventilation (MV) is scarce; therefore, the correct indication of OLB is difficult to establish in such patients, and the available studies disagree about whether it is beneficial. Some authors 2, 3 consider OLB both safe and diagnostically useful, and believe that it influences therapeutic decisions, while others 4, 5 argue that it confers no survival benefit and entails additional morbidity and mortality. Because of these potential drawbacks, many clinicians are reluctant to perform OLB in patients on MV. However, cases of lung disease of unknown aetiology and refractory to empirical treatment require an accurate histological diagnosis so that specific therapy can be started. We aimed to determine the diagnostic yield, changes to diagnosis and therapy, complications, and mortality of OLB performed in patients with suspected diffuse lung disease on MV.
Material and methods
We performed a retrospective study of the clinical files of patients admitted to the adult Multidisciplinary Intensive Care Units of S. João Hospital between January 1999 and July 2007 (8.5 years). The inclusion criteria were respiratory failure requiring MV and diffuse lung infiltrates for which OLB was indicated. Patients who were placed on MV after OLB or were biopsied during a thoracotomy performed for therapeutic purposes were excluded. The data obtained on the subjects included demographic data, comorbidities, suspected diagnosis on ICU admission, diagnostic tests performed before OLB (including computed tomography (CT) of the chest and bronchoscopy), treatment administered prior to OLB, PaO 2 /FiO 2 and PEEP levels before and after OLB, the histological diagnoses obtained and their influence on patient management, and complications and mortality associated with the surgical procedure. All biopsies were performed via thoracotomy (mostly minithoracotomy) on sites selected based on imaging abnormalities. A maximum of 3 lung tissue samples were taken for histological analysis. After lung tissue was obtained, all patients had their pleural spaces drained using 2 pleural drains, which were removed as early as possible if there were no air leaks. Statistical analysis was performed using SPSS 14.0., with p<0.05 considered significant.
Results

Pre-OLB demographic and clinical data
OLB is seldom performed in our institution, with an annual rate of 0.2%-0.6% of patients admitted to the ICU at S. João Hospital. Nineteen patients met our inclusion criteria. Mean patient age was 58±16.3 years, 10 (53%) were male, 5 (26.3%) were immunodepressed, and 12 (63.2%) had previously diagnosed comorbidities. Before the biopsy, all patients underwent CT of the chest and 15 (79%) patients had had fiberoptic bronchoscopy. When OLB was performed, 12 (63.2%) patients were on antibiotic therapy, 14 (73.7%) were receiving steroids, 4 (21.1%) were on inotropic support, PEEP (n=16) and PaO 2 /FiO 2 (n=18) levels were, on average, 9 cmH 2 O and 171 mmHg, respectively. At the time of the OLB, patients had stayed on corrigenda average 13±7 days in the ICU. Duration of MV before the procedure was 11.8 days for survivors and 14.9 days for non survivors, a difference that was not statistically significant (p=0.6).
Intra-and peri-operative complications and physiological abnormalities
There were no intra-operative complications. Four patients (21%) developed complications, all of which consisted of persistent air leak lasting 4 to 27 days, and one patient required inotropic support after OLB. Mean post-OLB PaO 2 /FiO 2 and PEEP were 202 mmHg and 8 mmHg, respectively. The levels of these parameters were not significantly different before and after the biopsy.
Histological diagnoses
The diagnostic yield was 95%. Only one patient had an inconclusive diagnosis because of small sample size. Table I shows the histological diagnoses. Diffuse alveolar damage (DAD) ( Fig. 1 ) was the most common diagnosis, found in 7 patients, 6 of which were in the disease's fibroproliferative stage and 1 in the exudative stage. Two patients with no known prior lung pathology had abnormalities compatible with DAD on histology, as well as features compatible with usual interstitial pneumonia. Given these findings, acute exacerbation of idiopathic pulmonary fibrosis (IPF) was diagnosed after other causes of IPF decompensation were ruled out ( Fig. 2) . One female patient, admitted to hospital with respiratory insufficiency and pulmonary thromboembolism (PTE), was admit-ted to the ICU following cardiorespiratory arrest (CRA). Imaging abnormalities suggested diffuse lung disease, and an OLB was performed because her clinical presentation was suspected to be caused by another underlying disease. The biopsy revealed no abnormalities other than recent, organised thrombus. The 2 cases of organising pneumonia (OP) were associated with Pseudomonas aeruginosa infection (1 case) and Legionella infection (1 case) ( Fig. 3) . Two patients were diagnosed with eosinophilic pneumonia, and one of them underwent a bronchoscopy. However, a total and differential cell count could not be performed in the bronchoalveolar lavage (BAL) because the sample's yield was insufficient. BAL cell counting was not performed in the other patient because the diagnosis was not suspected. One patient was admitted to the ICU after suffering CRA during a fiberoptic bronchoscopy performed for DLD workup. Since the patient still did not have a definitive diagnosis, an OLB was performed and the histological findings were compatible with sarcoidosis. Viral pneumonia was diagnosed by histological analysis in one patient and by molecular biology techniques (positive test for Cytomegalovirus (CMV) DNA in a lung biopsy fragment) in another. Fungal pneumonia with Candida spp. characteristics was diagnosed by visualisation of fungal structures and confirmed by histochemical methods using PAS, PAS-D and Grocott methods.
The impact of the histological diagnosis on management and outcomes
The OLB results led to review of the initial diagnosis in 14 patients (74%) and influ- It is important to note that 3 patients died before the biopsy results became available.
Overall mortality was 47% (9 patients). Of the 10 patients who survived to discharge, 4 (40%) had their management influenced by the biopsy results; of the 9 patients who died, 4 (44.4%), had their treatment influenced by the histological diagnosis. Three of the 4 patients who developed complications died and 1 was discharged from hospital. Their deaths were caused by acute exacerbation of IPF, cardiac and pulmonary thrombi (autopsy finding) and sepsis with multiorgan dysfunction.
Discussion
OLB is rarely performed in the ICU. In the USA, the annual rate is 0-0.9% 6 . The deci- corrigenda sion to perform the procedure in patients on MV depends on the need for an accurate diagnosis, which is a prerequisite for starting specific therapy, avoiding the side effects of ineffective empirical treatment, and obtaining prognostic information 6 . In our study, OLB had a diagnostic yield of 95%, and only one patient remained without a diagnosis because the sample was too small. This rate is comparable to that reported in the literature 7, 8 (> 92%), but it is important to point out that an ideal sample must have at least 3 cm in its greatest dimension and originate from more than one lobe 9 . Despite the similar diagnostic yield 10 , we preferred thoracotomy to videothorascopy for biopsy because the former takes less time and requires neither replacement of the orotracheal tube with a double-lumen tube, nor selective ventilation of one lung. In addition, the diagnostic yield of OLB in patients on MV was similar to that observed in a study of outpatients with diffuse lung disease referred for OLB, which did not require prior ventilatory support 3,10-13 . While the OLB results led to review of the initial diagnosis in 14 patients (74%), it only affected the management of 8 (42%) cases. This rate is lower than that seen in other studies 6, [11] [12] [13] (64 -75%) and can be explained in part by 3 patients having died before the biopsy result was known, (2 were later diagnosed with acute exacerbation of IPF and 1 with eosinophilic pneumonia). These diagnoses could have influenced treatment and prognosis in all these cases, particularly the last one. Seven patients were diagnosed with DAD. In these cases, knowing the DAD stage had an important influence on treatment, even though histology did not reveal the under-lying cause, because, as Meduri et al. 14 
have
shown, steroids can improve survival in patients in the fibroproliferative stage. When the clinical picture is compatible and there is no known predisposing factor to DAD, a diagnosis of acute interstitial pneumonia 15 (AIP) is made. Some patients in this study could have AIP, but infectious causes could not be definitely ruled out because the biopsy fragments were not subjected to exhaustive microbiology studies, particularly virology assays. The time interval between ICU admission on MV and the OLB (mean 13 days) was greater than in other similar studies 13, 16, 17 (3 -8 days) . The impact of the duration of MV before lung biopsy on clinical outcomes has not been established. Some authors, however, suggest that early OLB is advantageous. Warner et al. 5 reported that time interval between the onset of respiratory failure and performance of OLB was significantly shorter in survivors (4.4±2.9 days) than in non survivors (6.1±3.6 days). In the study by Lim et al. 16 , patients who underwent OLB within a week of starting MV had a greater chance of survival (63% vs. 11%; p=0.018), even though there were no differences in MV time between the survivors and non survivors group. Araby et al. 18 , however, found no difference in time on MV before biopsy in survivors and non survivors. We found no significant difference in time on MV prior to biopsy in survivors and non survivors either (11.8 days vs. 14.9 days; p=0.6). There were no significant differences in the levels of PEEP and PaO 2 /FiO 2 before and after OLB, and only one patient needed OLB inotropic support after OLB. Therefore, we concluded that this surgical proce-corrigenda
